Newsroom:Top News and Events

Exciting things are happening at NexImmune. Below you will find the latest news about our company, technology, pipeline and leadership.

FEBRUARY 06, 2024

NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Read More >

FEBRUARY 02, 2024

NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Read More >

OCTOBER 24, 2023

NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes

Read More >